What is the primary revenue source for Gilead Sciences (GILD)?

According to the latest financial reports, the company's revenue is driven by its core business segments and operational services. You can explore the exact breakdown and proportions of each revenue stream using the interactive charts on this page.

How can I visualize and analyze GILD's financial statements?

gkcal provides interactive Sankey diagrams and profit waterfall charts that map out Gilead Sciences's total revenue, cost of goods sold, operating expenses, and net income, making it easy to understand their business model and cash flow at a glance.

How Gilead Sciences Makes Money: GILD Revenue Breakdown (2026)

Operations

Where did the money come from, and where was it spent?

Insufficient data

Current data explains this period's structure but is insufficient for a year-over-year conclusion.

Revenue: USD 14.76B
Largest revenue segment share (HIV Products, Biktarvy): 48.32%
Selling, general and administrative: USD 3.37B
Research and development: USD 3.14B

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Research and developmentResearch and development expenses · ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Largest revenue segment share (HIV Products, Biktarvy)HIV Products, Biktarvy · segment_value / revenue * 100
RevenueTotal revenues · RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrativeSelling, general and administrative expenses · SellingGeneralAndAdministrativeExpense

Assets

Where is the money tied up, and how is the company financed?

Insufficient data

Current data explains this period's structure but is insufficient for a year-over-year conclusion.

Goodwill: USD 8.31B
Property, plant and equipment: USD 5.83B
Accounts receivable: USD 5.05B
Shareholder equity: USD 11.74B

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Shareholder equityTotal stockholders’ equity · StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Accounts receivableAccounts receivable, net · AccountsReceivableNetCurrent
GoodwillGoodwill · Goodwill
Property, plant and equipmentProperty, plant and equipment, net · PropertyPlantAndEquipmentNet

Some conclusions lack complete source metrics and should be interpreted cautiously.

Cash

Did accounting profit ultimately turn into cash?

Insufficient data

Current data explains this period's structure but is insufficient for a year-over-year conclusion.

Free cash flow remains positive after capital expenditure.

Operating cash flow: USD 6.12B
Free cash flow: USD 5.86B

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Free cash flowcfo - capex
Operating cash flowsum(waterfull.operating)

Some conclusions lack complete source metrics and should be interpreted cautiously.

Shareholders

Did the money earned actually make its way back to shareholders?

Steady

Dividends and net buybacks are covered by free cash flow, so cash genuinely reached shareholders.

Cash dividends: USD 2.07B
Share repurchases: USD 774.00M
Stock issuance proceeds: USD 175.00M
Net shareholder return: USD 2.67B

View calculation evidence

YoY periods: H1 2026 compared with H1 2025

Source metrics

Cash dividendsPayments of dividends · PaymentsOfDividends · abs(node_value)
Net shareholder returndividends_paid + share_repurchases - stock_issuance_proceeds
Share repurchasesPayments for repurchase of common stock · PaymentsForRepurchaseOfCommonStock · abs(node_value)
Stock issuance proceedsProceeds from issuances of common stock · ProceedsFromIssuanceOfCommonStock · abs(node_value)

Diluted share count is missing, so dilution cannot be assessed against buybacks.

Financial Insights

Please select a report to view

Where did the money come from, and where was it spent?

Where is the money tied up, and how is the company financed?

Did accounting profit ultimately turn into cash?

Did the money earned actually make its way back to shareholders?